Your session is about to expire
← Back to Search
Cognitive Intervention with Leisure Activities for Cognitive Impairment
N/A
Waitlist Available
Led By Sylvie Belleville, PhD
Research Sponsored by Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Have a Montreal Cognitive Assessment (MoCA) total score of 20 and above
Be older than 18 years old
Must not have
Presence of disease or injury of the central nervous system
Symptomatic stroke within the previous year
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre (within 12 weeks before intervention starts) + post-1 (within 8 weeks after the end of intervention) + post-2 (2 years from pre, +/- 3 months)
Awards & highlights
No Placebo-Only Group
Summary
This trial will test a cognitive intervention meant to increase cognitive and brain reserve in people with subjective cognitive decline.
Who is the study for?
This trial is for individuals with subjective cognitive decline who are worried about their memory, have certain scores on memory and cognition tests, can commit to the full intervention plus follow-ups, and have internet at home. Excluded are those with recent major surgery or serious illness, substance abuse issues, no study partner, insufficient English/French proficiency in Toronto/Montreal respectively, or extensive music training.
What is being tested?
The trial is testing a program that combines cognitive training sessions with engaging leisure activities like Spanish lessons or music appreciation (ENGAGE SPANISH/MUSIC) versus discovery-based learning (ENGAGE DISCOVERY). It's designed to see if these activities can boost brain function in people noticing early memory problems.
What are the potential side effects?
Since this trial involves non-medical interventions such as cognitive exercises and leisure activities rather than drugs or medical procedures, traditional side effects are not expected. However, participants may experience fatigue or frustration.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My cognitive function score is 20 or higher.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have a disease or injury affecting my brain or spinal cord.
Select...
I have had a stroke that caused symptoms in the past year.
Select...
I have had surgery on my brain.
Select...
I have not had major surgery in the last 2 months.
Select...
I have a serious health condition that could lead to death within a year.
Select...
I have been diagnosed with major depression or anxiety.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ pre (within 12 weeks before intervention starts) + post-1 (within 8 weeks after the end of intervention) + post-2 (2 years from pre, +/- 3 months)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre (within 12 weeks before intervention starts) + post-1 (within 8 weeks after the end of intervention) + post-2 (2 years from pre, +/- 3 months)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Changes in episodic memory (composite score)
Secondary study objectives
Changes in attention control (composite score)
Changes in brain function: Brain activation (for a subgroup of participants)
Changes in brain structure: Cortical Thickness (for a subgroup of participants)
+5 moreOther study objectives
Transfer to everyday life (performance-based): Instrumental Activities of Daily Living
Transfer to everyday life (performance-based): Memory Strategies
Transfer to everyday life (self-reported): Activities of daily living
+4 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: ENGAGE SPANISH/MUSICExperimental Treatment1 Intervention
Cognitive strategies to improve attention and memory skills and application in selected leisure activities (music or Spanish lessons, and videogames) over 4 months.
Group II: ENGAGE DISCOVERYActive Control1 Intervention
Educational program about brain and healthy aging complemented by learning of new information with videogames, documentaries and group discussions over 4 months.
Find a Location
Who is running the clinical trial?
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,392 Previous Clinical Trials
26,529,298 Total Patients Enrolled
Centre de Recherche de l'Institut Universitaire de Geriatrie de MontrealLead Sponsor
23 Previous Clinical Trials
8,776 Total Patients Enrolled
Rotman Research Institute at BaycrestOTHER
10 Previous Clinical Trials
318 Total Patients Enrolled
Sylvie Belleville, PhDPrincipal InvestigatorCentre de Recherche de l'Institut Universitaire de Geriatrie de Montreal
5 Previous Clinical Trials
422 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have a disease or injury affecting my brain or spinal cord.I have had surgery on my brain.I have a serious health condition that could lead to death within a year.I have had a stroke that caused symptoms in the past year.I have not had major surgery in the last 2 months.My cognitive function score is 20 or higher.I have been diagnosed with major depression or anxiety.I can commit to the entire study and follow-ups for 2 years.
Research Study Groups:
This trial has the following groups:- Group 1: ENGAGE SPANISH/MUSIC
- Group 2: ENGAGE DISCOVERY
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.